The NGF System and its interplay with endocannabinoid signalling, from peripheral sensory terminals to the brain: new targets for the development of next generation drugs for neuropathic pain

Milano, Italy

  • Insitute presentation

    Genomnia was established in Milan in October 2008 as an autonomous enterprise, having a minority partnership with AB MEDICA, focused on building and making the most of strong and solid knowhow in the main fields of genomics.

    In 2011 Genomnia became one of the first Italian ISO 9001 certified SME for projection and delivery of Massive Sequencing Services for nucleic acids and Bioinformatic analysis by exploiting High– Throughput (SOLID 5500Xl, ION Torrent) sequencing technology.Through active participation in both Italian and international projects, Genomnia has developed and validated analytical models and proprietary algorithms that have enabled the company to achieve high standards of consistency and strong analytical reproducibility. Our team includes highly experienced professionals in the fields of Neurobiology, Molecular Biology and Bioinformatics.

    Corporate skills cover the production of Next Generation Sequencing (NGS) data and the fieldof Bioinformatic analysis applied to biomedicine projects with special focus on DNA and RNAapplications.

  • Project Staff


    Dr. Anna Moles

    BSc Biological Sciences (Parma, Italy)-Ph.D Animal Biology (Firenze, Italy)

    After a post doc in Hepatology (University of Modena, Italy) Anna Moles moved for one year to the Department of Biostatistics of the INRAN where she participated to nutritional studies in European cohort. In 1998 she joined the CNR, Institute of Neuroscience where she has worked for 10 years on animal models of psychiatric disorders and drug discovery. In 2008 she has been visiting Professor at the USTL, University of Lille 1 in the field of Neuroscience. She is author of more than 50 publications in peer reviewed journals including Science and PNAS. She is Scientific Director at Genomnia since February 2009.


    Dr. Armando Felsani

    senior researcher at Genomnia from 2009

    Armando Felsani is author of more than 65 publications in peer reviewed journals, accumulating a vast research experience in gene expression and gene regulation in cell cycle and differentiation.


    GuffantiDr. Alessandro Guffanti

    BSc in Biological Sciences (Milano), MSc in Computer Science (Hertfordshire),
    MSc inBiomedical Statistics (Milano)


    Alessandro Guffanti expertise is on transcriptome and genome qualitative and quantitative sequence analysis, gene identification and bioinformatics programming. From March 2009 he is in charge of bioinformatics analyses and bioinformatic systems at Genomnia.

    BriniDr. Elena Brini

    BSc in Biotechnology, PhD in Molecular Medicine, MSc in Management of Intellectual Property



    Elena Brini gained her PhD working on a gene expression study of Multiple Sclerosis patients and on animal models using a range of microarray platforms. She was a graduate fellow at Chiron Vaccines s.p.a. (Siena, Italy) and a visiting PhD student at Merck-Serono (Boston,USA and Ivrea, Italy). She has been working in Genomnia since January 2009 where she supervises and performs all laboratory activities.


    ColaiacovoDr. Moreno Colaiacono

    M.Sc. in Bioinformatics, PhD in Complex Systems in Medicine and Life Sciences


    Moreno Colaiacovo got his M.Sc. degree in Bioinformatics in 2008 from the University of Milan-Bicocca, with a thesis on the prediction of gene regulatory networks. From 2009 to 2013 he works at the CRA-GPG Genomics Centre in Fiorenzuola d’Arda, where he studies gene regulation mediated by plant microRNAs. In the context of an international research project, he is involved in the sequencing of the bread wheat genome, which was published in Science in July 2014. In February 2013, he obtains his PhD in Complex Systems in Medicine and Life Sciences from the University of Turin. In September 2013 he joins the bioinformatics team of Genomnia srl, where he performs computational analyses of genomics and transcriptomics data. He loves science communication and writes articles for websites and magazines